Skip to content

Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides

Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03526081
Enrollment
17
Registered
2018-05-16
Start date
2015-01-20
Completion date
2016-07-30
Last updated
2019-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

flavone, ADME, apigenin, parsley, chamomile, polyphenols

Brief summary

Probe dietary intervention study in healthy young adult males to evaluate the concentration of apigenin derived metabolites in plasma and urine after single acute intakes of different apigenin-containing test materials.

Detailed description

Flavonoids, including the sub groups of Flavones (FO) are plant-derived compounds commonly present in the human diet. Examples of FO-containing foods and beverages are parsley, celery, and chamomile. The study described below will provide initial information of apigenin derived metabolites in humans. The investigators suggest the information that will be obtained from the outlined work will be particularly timely given increasing interest in the putative health effects of FO intake in humans. This study consisted of two parts. The first part consisted of a probe study in which the investigators investigated the absorption and metabolism from four flavone-containing test products. The second phase investigated absorption and metabolism after the intake of a flavone-containing parsley drink.

Interventions

Chamomile Tea in 300mL hot water

OTHERParsley based drink

3.2 g dried parsley in 300mL hot water

OTHERParsley Yogurt

3.2 g dried parsley in 100g plain yogurt

Apigenin capsule mixed with 300mL hot water

OTHERParsley-based drink (II)

3.2 g dried parsley in 300mL hot water

Sponsors

Mars, Inc.
CollaboratorINDUSTRY
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Masking description

Investigator doing data analysis and statistical analyses

Intervention model description

Cross-over dietary intervention study in healthy young adult males

Eligibility

Sex/Gender
MALE
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* No prescription medications * BMI 18.5 - 29.9 kg/m2 * Weight ≥ 110 pounds * previously consumed cocoa, peanut, parsley, celery and chamomile products with no adverse reactions

Exclusion criteria

* Adults unable to consent * Prisoners * Non-English speaking * BMI ≥ 30 kg/m2 * Performing vigorous physical activity (i.e. more than 6 metabolic equivalence of task (MET) as defined by Centers for Disease Control and Prevention (CDC) and American College of Sports Medicine (ACSM) guidelines) for more than 3 days a week * Dietary allergies including those to nuts, cocoa and chocolate products, parsley, celery and chamomile. * Active avoidance of coffee and caffeinated soft drinks * Under current medical supervision * A history of cardiovascular disease, stroke, renal, hepatic, or thyroid disease * History of clinically significant depression, anxiety or other psychiatric condition * History of Raynaud's disease * History of difficult blood draws * Indications of substance or alcohol abuse within the last 3 years * Current use of herbal, plant or botanical supplements (multi-vitamin/mineral supplements are allowed) * Blood Pressure \> 140/90 mm Hg * GI tract disorders, previous GI surgery (except appendectomy) * Self-reported malabsorption (e.g. difficulty digesting or absorbing nutrients from food, potentially leading to bloating, cramping or gas) * Diarrhea within the last 3 months, or antibiotic intake within the last 3 months * Vegetarian, Vegan, food faddists, individuals using non-traditional diets, on a weight loss diet or individuals following diets with significant deviations from the average diet * Metabolic panel and cholesterol results or complete blood counts that are outside of the normal reference range and are considered clinically relevant by the study physician * Cold, flu, or upper respiratory condition at screening * Currently participating in a clinical or dietary intervention study

Design outcomes

Primary

MeasureTime frameDescription
Flavone metabolites in plasmabefore to 6 h post test material intakeConcentration of flavone metabolites in plasma
Flavone metabolites in urine12 h before to 24 h post test material intakeAmount of flavone metabolites excreted in urine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026